Ken Griffin’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-35,534
Closed -$904K – 15625
2026
Q2
$904K Buy
35,534
+21,591
+155% +$452K ﹤0.01% 8451
2026
Q1
$278K Sell
13,943
-29,700
-68% -$700K ﹤0.01% 10648
2025
Q4
$1.16M Buy
+43,643
New +$1.12M ﹤0.01% 7069
2025
Q3
– Sell
-1,508,298
Closed -$25M – 14537
2025
Q2
$25M Buy
1,508,298
+578,168
+62% +$12.6M ﹤0.01% 1892
2025
Q1
$23.2M Buy
+930,130
New +$21.4M ﹤0.01% 1873

Other funds holding KMTS

Ken Griffin's KMTS Position: Q3 2026 in Review

Ken Griffin sold out of Kestra Medical Technologies (KMTS) in Q3 2026, closing a stake of 35,534 shares — an estimated $904K sold.

Ken Griffin first reported a position in KMTS in Q1 2025 and held it in 5 quarters. The position peaked at $25M in Q2 2025. 122 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

  • Ken Griffin reported no remaining Kestra Medical Technologies position as of Q3 2026 after selling out during the quarter.
  • Ken Griffin sold 35,534 Kestra Medical Technologies shares in Q3 2026, an estimated $904K.
  • Ken Griffin first reported a position in Kestra Medical Technologies in Q1 2025 and held it in 5 quarters.
  • Ken Griffin's Kestra Medical Technologies position peaked at $25M in Q2 2025.
  • 122 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.